A Study to Evaluate the MNV-201 in Patients With Low Risk MDS

NCT06465160 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelodysplastic Syndromes

Interventions

BIOLOGICAL: MNV-201 (Autologous CD34+ Cells Enriched with allogenic Placenta Derived Mitochondria)

Sponsor

Minovia Therapeutics Ltd.